Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer-Vicuron: Fill Pipeline, Minimize R&D Expense

Jul 01 2005

Related Content

A Recipe for Acquisition: the Esperion Strategy

Jan 01 2004

Pfizer Trims Altana From Pipeline

Jul 01 2005

Licensing Vivitrex: A Win for the Mid-sized Pharma and Specialists

Jul 01 2005

Double Blow to Branded Firms

Jul 01 2005

Versicor/Biosearch Italia: Merging as Equals

Sep 01 2002

Related Companies

Pfizer Inc.

Pfizer Inc.

Esperion Therapeutics, Inc.

Merck & Co., Inc.

Astellas Pharma, Inc.

Roche Holding AG

Cubist Pharmaceuticals, Inc.

Johnson & Johnson

Basilea Pharmaceutica Ltd.

Wyeth

Innoviva, Inc.

Eli Lilly and Company

UCB S.A.

UCB S.A.

Altana AG

Boehringer Ingelheim GmbH

Novartis AG

GSK plc

Schering-Plough

Bristol Myers Squibb Company

Gilead Sciences, Inc.

Sanofi Genzyme

Takeda Pharmaceutical Co. Ltd.

Cephalon, Inc.

Additional Topics

Business Strategies BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window